Atrial fibrillation screening remains debated, with experts disagreeing on whether current evidence justifies implementation or if randomized trials are needed to avoid overdiagnosis.
Absolute Event Rate: 0% vs 0%
Current evidence is sufficient to justify a national screening programme, argues Mark Lown, but Patrick Moran thinks there are too many unanswered questions and evidence from randomised trials is needed to avoid overdiagnosis
Building similarity graph...
Analyzing shared references across papers
Loading...
Mark Lown
University of Southampton
Patrick Moran
Trinity College Dublin
BMJ
University of Southampton
Trinity College Dublin
Building similarity graph...
Analyzing shared references across papers
Loading...
Lown et al. (Wed,) reported a other. Atrial fibrillation screening remains debated, with experts disagreeing on whether current evidence justifies implementation or if randomized trials are needed to avoid overdiagnosis.
synapsesocial.com/papers/6a21d4744c1bee377cecb529 — DOI: https://doi.org/10.1136/bmj.l43
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: